Facebook Pixel Code

Nippon India Pharma Fund - Direct Plan - IDCW

Sectoral/Thematic
Very High Risk
Rs 170.50  
-1.18
  |  
 NAV as on Sep 22, 2025
Benchmark
BSE Healthcare Total Return
Expense Ratio
0.89%
Fund Category
Equity - Sectoral/Thematic
Fund Size
Rs 8,357 Crores
Exit Load
1.00%
Min. Investment
Rs 5,000

Nav Chart

1W
1M
3M
6M
YTD
1Y
3Y
5Y
10Y

Asset Allocation

Sector Allocation

Nippon India Pharma Fund - Direct Plan - IDCW Fund Details

Investment Objective - The primary investment objective of the scheme is to seek to generate continuous returns by investing in equity and equity related or fixed-income securities of Pharma and other associated companies.

Return Since Launch
24.96%
Launch Date
Jan 1, 2013
Type
Open Ended
Riskometer
Very High

Ratio Analysis

Standard Deviation
15.03 vs NA
Fund Vs Category Avg
Beta
0.88 vs NA
Fund Vs Category Avg
Sharpe Ratio
1.07 vs NA
Fund Vs Category Avg
Portfolio Turnover Ratio
14.00 vs NA
Fund Vs Category Avg

Performance Analysis

1W
1M
3M
6M
1Y
3Y
5Y
10Y
SI
Fund Returns (%)-0.10-0.752.406.2715.1918.6013.466.7824.96
Category Average (%)0.121.883.7611.49-1.0310.029.61NA15.54
Rank within Category741853500818754194412317109

* Returns over 1 year are CAGR

Peer Comparision

Scheme Name(IDCW Direct)
NAV (Rs)
AUM (Rs Cr)
1W(%)
1M(%)
3M(%)
6M(%)
1Y(%)
3Y(%)
5Y(%)
10Y(%)
SI(%)
ER(%)
26.3629,8710.191.622.0110.25-6.9213.9023.19NA15.600.63
135.2714,734-0.780.66-6.531.55-10.6311.9915.4412.2622.730.96
20.8213,643NA1.464.0513.89-2.4414.75NANA16.980.74
11.3811,537-0.243.407.6515.380.88NANANA10.020.77
10.3510,1230.392.271.979.871.77NANANA2.990.53
74.909,6880.150.200.1111.03-4.126.6414.707.9217.141.01
10.749,4120.311.891.739.99-8.10NANANA4.690.88
42.938,3710.411.231.7613.929.5319.2324.6816.8914.800.77
170.508,357-0.10-0.752.406.27-6.9218.6013.466.7824.960.89
49.247,645-0.101.281.7611.23-5.5621.9430.7013.4913.341.14
View All
Sep 22, 2025

Return Calculator

Over the past

Invested
5000
  • Invested Amount
  • Estimated Return

Total investment of ₹5000

Would have become ₹4,654 (-6.92%)

Fund Manager

Sailesh Raj Bhan
Kinjal Desai

Mr. Sailesh Raj Bhan has about 19 years experience in equity research and fund management, with over 10 years at Reliance Nippon Life Asset Management Limited (formerly Reliance Capital Asset Management Limited). He manages diversified equity schemes like Reliance Equity Opportunities Fund (the largest Flexicap Scheme in India with assets of USD 800 million) since its inception in 2005 and Reliance Top200 Fund (a large cap diversified equity fund) since its inception in 2007. In addition, for over 9 years, he has been managing two specialized sector funds Reliance Pharma Sector Fund (the largest pharma sector fund in India) and Reliance Media and Entertainment Fund.

View More

Here is the list of funds managed by Sailesh Raj Bhan

Scheme Name(IDCW Direct)
Category
NAV(Rs)
AUM(Rs Cr)
1Y(%)
5Y(%)
Equity - Multi Cap93.4246,216-6.9825.76
Equity - Large Cap43.3145,012-2.2220.48
Equity - Sectoral/Thematic170.508,357-6.9213.46
Sep 22, 2025

Top Performing Related Funds

Scheme Name(IDCW Direct)
NAV (Rs)
AUM (Rs Cr)
1W(%)
1M(%)
3M(%)
6M(%)
1Y(%)
3Y(%)
5Y(%)
10Y(%)
SI(%)
ER(%)
105.6564,821-0.041.663.1813.50-12.1014.4426.9317.7420.350.64
93.4246,216-0.371.203.5013.70-6.9815.0425.769.4719.190.73
43.3145,012-0.091.723.3912.18-2.2213.7720.488.8912.210.69
193.4238,386-0.211.203.0614.81-7.1417.5624.0610.0026.200.71
17.8815,5060.070.331.353.276.997.646.113.854.670.38
48.3014,9340.151.252.5811.36-9.1312.6521.348.0713.171.02
Sep 22, 2025
icon
Market Data